Parnassus Investments, LLC / BMRN
Parnassus Investments, LLC’s Biomarin Pharmaceutical Inc Position
Does Parnassus Investments, LLC own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 873.0K shares worth $76M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$76M
Q1 2024
Shares
873.0K
% of Portfolio
+0.16%
Quarters Held
16
position exited
Position History BMRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 873.0K | $76M | +0.16% |
| Q4 2023 | 1.85M | $178M | +0.40% |
| Q3 2023 | 2.34M | $207M | +0.51% |
| Q2 2023 | 2.34M | $203M | +0.47% |
| Q1 2023 | 2.34M | $227M | +0.56% |
| Q4 2022 | 2.34M | $242M | +0.60% |
| Q3 2022 | 2.57M | $218M | +0.57% |
| Q2 2022 | 2.78M | $230M | +0.55% |
| Q1 2022 | 2.73M | $210M | +0.43% |
| Q4 2021 | 2.73M | $241M | +0.46% |
| Q3 2021 | 2.68M | $208M | +0.44% |
| Q2 2021 | 2.68M | $224M | +0.49% |
| Q1 2021 | 2.68M | $203M | +0.49% |
| Q4 2020 | 1.52M | $133M | +0.36% |
| Q3 2020 | 187.1K | $14M | +0.04% |
| Q2 2020 | 89.7K | $11M | +0.04% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parnassus Investments, LLC’s full portfolio or all institutional holders of BMRN.